Int Pharmacopsychiatry. 1976;11(1):8-15.

5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.

Abstract

Through a controlled double-blind study in 30 hospitalized patients affected with endogenous depression, the antidepressant action of the combination of nialamide+l-5-HTP has been evaluated and compared with a control group which only received nialamide (+ placebo). The patients treated with nialamide + l-5-HTP achieved a fuller recovery than those who were treated with nialamide alone. The treatment with nialamide + l-5-HTP proved to have a shorter delay of onset. Side effects showed no marked differences except for the orthostatic hypotension which was less apparent in those patients treated with nialamide + l-5-HTP.

PMID:: 770365; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Medical

Depression - MedlinePlus Health Information

Molecular Biology Databases

5-HYDROXYTRYPTOPHAN - HSDB

Supplemental Content

Save items

Related citations in PubMed

The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. [Arch Psychiatr Nervenkr. 1977]
The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
Angst J, Woggon B, Schoepf J. Arch Psychiatr Nervenkr. 1977 Oct 11; 224(2):175-86.
Tryptophan and an MAOI (nialamide) in the treatment of depression. A double-blind study. [Int Pharmacopsychiatry. 1971]
Tryptophan and an MAOI (nialamide) in the treatment of depression. A double-blind study.
Ayuso Gutierrez JL, Aliño JJ. Int Pharmacopsychiatry. 1971; 6(2):92-7.
[New therapeutic possibilities in depression: 5-hydroxytryptophan]. [Actas Luso Esp Neurol Psiquiat...]
[New therapeutic possibilities in depression: 5-hydroxytryptophan].
López-Ibor Aliño JJ, Ayuso Gutiérrez JL, Montejo Iglesias ML. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1975 May-Jun; 3(3):151-62.
Review Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. [Pharmacol Ther. 2006]
Review Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
Turner EH, Loftis JM, Blackwell AD. Pharmacol Ther. 2006 Mar; 109(3):325-38. Epub 2005 Jul 14.
Review 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects. [J Clin Psychopharmacol. 1987]
Review 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
Byerley WF, Judd LL, Reimherr FW, Grosser BI. J Clin Psychopharmacol. 1987 Jun; 7(3):127-37.

See reviews... See all...

Cited by 1 PubMed Central article

Review Complementary and alternative medicine therapies to promote healthy moods. [Pediatr Clin North Am. 2007]
Review Complementary and alternative medicine therapies to promote healthy moods.
Kemper KJ, Shannon S. Pediatr Clin North Am. 2007 Dec; 54(6):901-26; x.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressio...
5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.
Int Pharmacopsychiatry. 1976 ;11(1):8-15.

PubMed
Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level i...
Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells.
Blood. 1995 Apr 1 ;85(7):1865-70.

PubMed
A neural network model of phantom limbs.
A neural network model of phantom limbs.
Biol Cybern. 1995 ;72(3):197-206.

PubMed
Suppression of cell-mediated immunity after infection with attenuated rubella vi...
Suppression of cell-mediated immunity after infection with attenuated rubella virus.
Infect Immun. 1976 Feb ;13(2):464-9.

PubMed
Simulation of charge-mutant acetylcholinesterases.
Simulation of charge-mutant acetylcholinesterases.
Biochemistry. 1995 Apr 4 ;34(13):4211-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information